FHTX logo

Foghorn Therapeutics (FHTX) Operating Expenses

Annual Operating Expenses

$122.89 M
-$19.17 M-13.50%

December 1, 2024


Summary


Performance

FHTX Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFHTXexpensesmetrics:

Quarterly Operating Expenses

$26.86 M
-$4.80 M-15.16%

December 1, 2024


Summary


Performance

FHTX Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherFHTXexpensesmetrics:

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

FHTX Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-13.5%-19.2%
3 y3 years+20.4%-30.5%
5 y5 years+140.6%-30.5%

FHTX Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-13.5%+20.4%-30.5%at low
5 y5-year-13.5%+140.6%-30.5%+95.7%
alltimeall time-13.5%+371.8%-30.5%+105.0%

Foghorn Therapeutics Operating Expenses History

DateAnnualQuarterly
Dec 2024
$122.89 M(-13.5%)
$26.86 M(-15.2%)
Sep 2024
-
$31.66 M(+1.7%)
Jun 2024
-
$31.12 M(-6.4%)
Mar 2024
-
$33.24 M(+6.5%)
Dec 2023
$142.06 M(+4.2%)
$31.23 M(-9.6%)
Sep 2023
-
$34.56 M(-8.2%)
Jun 2023
-
$37.65 M(-2.5%)
Mar 2023
-
$38.63 M(+7.1%)
Dec 2022
$136.37 M
$36.07 M(+3.4%)
Sep 2022
-
$34.89 M(+3.6%)
Jun 2022
-
$33.68 M(+6.2%)
DateAnnualQuarterly
Mar 2022
-
$31.72 M(+10.2%)
Dec 2021
$102.05 M(+48.0%)
$28.80 M(+9.5%)
Sep 2021
-
$26.30 M(+11.7%)
Jun 2021
-
$23.54 M(+0.5%)
Mar 2021
-
$23.42 M(+11.3%)
Dec 2020
$68.96 M(+35.0%)
$21.03 M(+12.7%)
Sep 2020
-
$18.67 M(+20.1%)
Jun 2020
-
$15.54 M(+13.2%)
Mar 2020
-
$13.72 M(-9.6%)
Dec 2019
$51.08 M(+96.1%)
$15.19 M(+15.9%)
Sep 2019
-
$13.10 M
Dec 2018
$26.05 M
-

FAQ

  • What is Foghorn Therapeutics annual total operating expenses?
  • What is the all time high annual operating expenses for Foghorn Therapeutics?
  • What is Foghorn Therapeutics annual operating expenses year-on-year change?
  • What is Foghorn Therapeutics quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Foghorn Therapeutics?
  • What is Foghorn Therapeutics quarterly operating expenses year-on-year change?

What is Foghorn Therapeutics annual total operating expenses?

The current annual operating expenses of FHTX is $122.89 M

What is the all time high annual operating expenses for Foghorn Therapeutics?

Foghorn Therapeutics all-time high annual total operating expenses is $142.06 M

What is Foghorn Therapeutics annual operating expenses year-on-year change?

Over the past year, FHTX annual total operating expenses has changed by -$19.17 M (-13.50%)

What is Foghorn Therapeutics quarterly total operating expenses?

The current quarterly operating expenses of FHTX is $26.86 M

What is the all time high quarterly operating expenses for Foghorn Therapeutics?

Foghorn Therapeutics all-time high quarterly total operating expenses is $38.63 M

What is Foghorn Therapeutics quarterly operating expenses year-on-year change?

Over the past year, FHTX quarterly total operating expenses has changed by -$6.38 M (-19.20%)